|
FY2025
12 months to Sep 26, 2025
|
FY2024
12 months to Sep 27, 2024
|
FY2023
1 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 24, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income including controlling interest | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Amortization of operating lease right-of-use assets | |||||
| Amortization of premium on investments | |||||
| Provision for doubtful accounts | |||||
| Deferred income taxes | |||||
| Impairment loss on internally developed software | |||||
| Share of net income of equity method investees, net of cash distributions | |||||
| Other non-cash items affecting net income | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract assets, net | |||||
| Inventories | |||||
| Operating lease right-of-use assets | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other liabilities | |||||
| Income taxes, net | |||||
| Contract liabilities | |||||
| Operating lease liabilities | |||||
| Other non-current liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Proceeds from maturities of available-for-sale securities | |||||
| Proceeds from sale of assets | |||||
| Purchases of property, plant and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of intangible assets | |||||
| Purchases of other investments | |||||
| Net cash provided by/(used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Repurchase of common stock | |||||
| Payment of cash dividend | |||||
| Distribution to controlling interest | |||||
| Payment of Excise Tax on Repurchase of Common Stock | |||||
| Purchase of noncontrolling interest in business combinations | |||||
| Equity issued in connection with business combination | |||||
| Shares repurchased for tax withholdings on vesting of restricted stock | |||||
| Payments for Deferred Consideration | |||||
| Net cash used in financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net increase/(decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosure: | |||||
| Cash paid for income taxes, net of refunds received | |||||
| Non-cash investing activities: | |||||
| Change in property, plant, and equipment purchased, unpaid at period-end | |||||
| Accrual of unpaid stock repurchase excise tax | |||||
| Equity issued in connection with business combination | |||||
Loading...